DNA Capital is a Brazilian venture firm investing in healthcare innovation and digital health solutions across the Brazilian market. The firm deploys capital across early to growth-stage healthtech companies, targeting entrepreneurs developing technology-enabled models that address gaps in access, efficiency, and quality within Brazil's healthcare ecosystem. DNA Capital's investment strategy reflects deep sector expertise rooted in operational healthcare experience, positioning it to support founders scaling solutions across telemedicine, health data platforms, diagnostic tools, and integrated care delivery models. The firm manages multiple venture funds and operates as an active investor, t...
Asset class
Impact theme
Investment geographies
